Skip to content

Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries

Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Patients With Acute Coronary Syndrome With Ectatic and Aneurysmatic Coronary Arteries

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05410678
Enrollment
63
Registered
2022-06-08
Start date
2015-06-01
Completion date
2022-04-01
Last updated
2022-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Ectasia

Brief summary

The aim of this study was to evaluate the efficacy and safety of renal stents implanted in ectatic/aneurysmatic coronary arteries.

Detailed description

In total, 18 patients (renal stent group) who underwent renal stent implantation in ectatic/aneurysmatic coronary arteries requiring percutaneous coronary intervention (PCI) and 45 patients who underwent large-sized bare metal coronary stent (BMCS) implantation (BMCS group) at our centre between 2015 and 2020 were included in the study. Control coronary angiography (CAG) was performed during the follow-up of these patients, and angiography-guided quantitative measurements were performed during PCI. The primary endpoints were myocardial infarction and cardiovascular mortality, and the secondary endpoints were restenosis and all-cause mortality.

Interventions

renal stent implantation in ectatic/aneurysmatic coronary arteries

Sponsors

Bursa Postgraduate Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute coronary syndrome patients * 18 year age * ectatic/aneurysmatic coronary arteries

Exclusion criteria

* Patients who underwent elective procedures, * experienced unsuccessful attempts * referred to surgical revascularization

Design outcomes

Primary

MeasureTime frameDescription
primary endpoints2 yearRate of myocardial infarction and cardiovascular mortality

Secondary

MeasureTime frameDescription
secondary endpoints2 yearRate of restenosis and all-cause mortality

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026